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Abstract 
Background: Efficient assessment of patients after ischemic stroke has important 
reference value for doctors to choose appropriate treatment and rehabilitation method 
for patients. Our study aimed to develop a new prognostic model for predicting 
outcomes three months after ischemic stroke among Chinese Population． 
Methods: A prospective observational cohort study among ischemic stroke patients 
presenting to Emergency Department in the Second Affiliated Hospital of Guangzhou 
Medical University was conducted from May 2012 to June 2013. Demographic data 
of ischemic stroke patients, assessment of NIHSS and laboratory results were 
collected. Based on three-month modified Rankin Scale (mRS) ischemic stroke 
patients were divided into either favorable outcome  (mRS: 0-2) or unfavorable 
outcome groups (mRS: 3-6). The variables closely associated with prognosis of 
ischemic stroke were selected to develop the new prognostic model consisted of four 
parameters: NIHSS, age, atrial fibrillation (AF), prealbumin (PA). The prognostic 
value of the modified prognostic model (NAAP: NIHSS+Age+AF+PA) was then 
compared with NIHSS alone. 
Results: A total of 454 patients with suspected stroke were recruited. 186 patients 
with ischemic stroke were included in the final analysis. There were 105 (56.5%) 
cases of ischemic stroke with favorable outcome, and 81 (43.5%) cases of ischemic 
stroke with unfavorable outcome. A new prognostic model, NAAP was developed. 
The area under curve (AUC) of NAAP was 0.861 (95%CI: 0.803-0.907), whilst the 
AUC of NIHSS was 0.783 (95%CI: 0.717-0.840), (P=0.0048). Decision curve 
analysis (DCA) showed that NAAP had a higher net benefit for threshold probabilities 
of 65% for predictive risk of poor outcomes. 
Conclusion: The modified prognostic model, NAAP may be a better prognostic tool 
for predicting 3-month unfavorable outcomes for ischemic stroke than NIHSS alone. 
 
Keywords: prognosis, ischemic stroke, NIHSS, emergency department, decision 
curve analysis. 
 
  
Background 
Ischemic stroke is a common disease in China and worldwide [1]. Although 
the mortality of ischemic stroke has been declining in recent years, the disability rate 
of ischemic stroke is still high [2]. In the United States about 800,000 people 
could not take care of their daily life by themselves due to ischemic stroke every year 
[3]. In China, stroke causes a heavy burden on society in the past 30 years [4]. 
Efficient assessment of patients after ischemic stroke is important as it allows doctors 
to choose appropriate early treatment and rehabilitation methods.  
The National Institutes of Health Stroke Scale (NIHSS) can reflect severity of 
neurological impairment and is recommended for prognosis of patients with ischemic 
stroke [5, 6]. However, many other factors are associated with the prognosis of 
patients with ischemic stroke, including age, gender, medical history, infarct size, 
location of ischemic stroke and complication, and biomarkers such as total bilirubin, 
uric acid and prealbumin [7-13].  Many prognostic models for ischemic stroke, 
including additional predictors to NIHSS have been published from the west but there 
are few studies from developing countries [7].  
The objective of this study was to develop a emergency department-based 
prognostic model for ischemic stroke in the Chinese population.  We applied a 
regression analysis to demographic data, medical history and clinical blood 
biomarkers of patients with ischemic stroke, and investigated which of these variables 
could improve the prognostic power of NIHSS alone in predicting 3-month post-
stroke modified Rankin  Scale. 
 
Methods 
Study design 
This study was a prospective observational study. Patients with ischemic stroke were 
recruited consecutively and followed up from May 2012 to June 2013. Ethical 
approval was obtained from the Clinical Research Ethics Committee of the Second 
Affiliated Hospital of Guangzhou Medical University (AHGZMU). 
  
Study setting 
This study was conducted in the Emergency Department (ED) of AHGZMU, 
which serves a population of approximately 1.56 million people in the Hai 
Zhu district, Guangzhou.  It is an academic hospital with 2500 beds affiliated 
with the Guangzhou Medical University. The ED receives more than 150 000 
new patients per annum and serves a local population of approximately 3030 
000 people. 
  
Inclusion and exclusion criteria 
Suspected stroke patients ≥ 18 years old presenting to the ED with symptoms or signs 
onset within 72 hours were recruited. Patients were excluded if they were <18 years 
old or had traumatic brain injury. 
 
Data collection 
Demographic data of ischemic stroke patients including gender, age, medical history, 
clinical manifestations, the assessment of NIHSS and laboratory results were 
collected. Ischemic stroke patients were divided into favorable outcome or 
unfavorable outcome groups based on the three-month modified Rankin Scale (mRS). 
All the doctors in this study have obtained the certification of NIHSS. Blood samples 
were drawn from patients with symptoms or signs onset within 72 hours. Laboratory 
results were collected from the Central Laboratory of AHGZMU. The modified 
Rankin Scale at 3 months (3month mRS) after ED diagnosis were recorded by phone 
interview. 
 
Statistical analyses 
Categorical variables were compared using Chi-square analysis, whilst continuous 
variables were compared using independent t-tests. Firstly, univariate logistic 
regression analysis was used on all variables, and results were presented as odds ratios 
(ORs) with 95%CI. Significant variables (p<0.05) were further analyzed using 
backward stepwise multivariate logistic regression and used to develop the prognostic 
model for ischemic stroke. mRS was used to distinguish between ischemic stroke 
patients with favorable (mRS: 0-2) and unfavorable (mRS: 3-6) outcomes. Prognostic 
performances of the new model and NIHSS were compared using receiver operating 
characteristic curve (ROC) analysis. Decision curve analysis (DCA) was used to 
compare the clinical usefulness of the new model and NIHSS the full range of 
threshold mortality risk probabilities [14]. All analyses were performed using SPSS 
v18.0 (SPSS Inc, IL, USA), MedCalc v12.7.0 (MedCalc Software, Mariakerke, 
Belgium) and the R statistical package (https://www.r-project.org, 
https://github.com/mdbrown/rmda). 
  
Results 
Demographic and clinical characteristics  
A total of 454 patients were recruited between May 2012 and June 2013. After 268 
exclusions, 186 cases with ischemic stroke were included in the final analysis. There 
were 105 (56.5%) cases of ischemic stroke with favorable outcome, and 81 (43.5%) 
cases of ischemic stroke with unfavorable outcome (Figure1). Compared with 
favorable outcome group, patients with unfavorable outcome were older, and had 
higher percentage of female, coronary heart disease, atrial fibrillation (AF). NIHSS 
score and concentrations of total bilirubin (TBIL) and monocyte counts (MON) in 
unfavorable group were higher than those in favorable outcome group. On the 
contrary, concentrations of uric acid (UA) and prealbumin (PA) in favorable group 
were higher than those in unfavorable group (Table 1). 
 
Logistic regression analysis of NIHSS and other variables 
Firstly, as shown in Table 2, univariate logistic regression was applied to analyze 
variables including gender, age, medical record, NIHSS, laboratory results for 
favorable outcome and unfavorable outcome groups. Variables showing statistical 
significance between two groups included male, age, coronary heart disease, AF, 
NIHSS, MON, TBIL, UA, PA . Secondly, those above variables were further 
analyzed by multivariate logistic regression. Only NIHSS, age, AF and PA showed 
statistical significance between the two groups. As shown in Table 3, the optimal cut-
off values and the area under curve (AUC) included  NIHSS (cut-off: >6, AUC: 0.783, 
95%CI: 0.717-0.840), age (cut-off: >79, AUC: 0.705, 95%CI: 0.634-0.770),  AF (cut-
off: Yes, AUC:0.587, 95%CI: 0.513-0.659),  PA (cut-off: ≤180 mg/L, AUC: 0.661, 
95%CI: 0.588-0.729). 
 
Prognostic performances of NAAP and NIHSS 
Comparison of NAAP and NIHSS was undertaken using ROC analysis (Figure 2). The 
area under curve (AUC) for NAAP was 0.861 (95%CI 0.803-0.907), whilst the AUC 
for NIHSS was 0.783(95%CI 0.717-0.840). Discrimination of the prognostic scores 
for 90-day unfavorable outcome showed that the modified NIHSS was superior to the 
original NIHSS (P=0.0048).  As shown in Figure 3, the net benefit for the modified 
and original NIHSS scores surpassed the strategies of treat all and treat none between 
threshold probabilities of 20% and 80%. Above a threshold probability of 65%, the 
two scores had a similar net benefit. Below a threshold probability of 65%, the NAAP 
became superior to the original NIHSS.  
 
Discussion  
In this study, the common predictors of prognosis of ischemic stroke were 
analyzed comprehensively and the modified prognostic model, NAAP was firstly 
developed based on NIHSS in Chinese population.  
Ischemic stroke is a common disease in Emergency Departments and 
prognosis of ischemic stroke is one of the most concerned problems to doctors, 
patients and family members. NIHSS is a 15-item scale which can reflect severity of 
neurological impairment of cerebral infarction. It is associated with infarct size and 3-
month prognosis of cerebral infarction [15-17]. Our results showed that the NIHSS 
score of favorable outcome group was lower than that of the unfavorable outcome 
group (6.1±5.69 vs14.01±9.07, p<0.001) and the OR of NIHSS score was 1.16 in the 
regression model. NIHSS was associated with unfavorable outcome after three 
months of cerebral infarction when the NIHSS score was >6 by ROC analysis, which 
was consistent with the results of an earlier research [5]. However, in our study, the 
AUC of NIHSS for predicting favorable outcome of ischemic stroke is 0.783, which 
suggested that the predictive effectiveness of NIHSS requires further improvement. 
In order to investigate factors that could improve the predictive effectiveness 
of NIHSS, our study summed up the patient's gender, age, medical history, NIHSS 
and routine blood test results. Univariate logistic regression was used to analyze all 
the above variables. Then variables with statistically significant were put into 
multivariate logistic regression analysis and NAAP was developed. Decision curve 
analysis and ROC analysis confirmed the clinical usefulness of NAAP.  Our results 
suggested that using NAAP to predict unfavorable outcome of ischemic stroke after 
three months might be better than using the original NIHSS.  
NAAP which was developed in the Chinese population was similar to many 
western prognostic models. Not only NIHSS was included in many models, but also 
age, as a common and important predictor, was included in the models [7]. Studies 
suggested that age was an independent risk factor for poor outcome in patients with 
ischemic stroke. Besides, age combined with NIHSS could be used to assess the risk 
of bleeding after thrombolysis treatment for ischemic stroke [18-21]. In our study, 
patients with favorable outcome were younger than those with unfavorable outcome 
(66.9±13.0 vs75.6±11.3 years old, p<0.001). By logistic regression and ROC analysis, 
age showed a good predictive performance for prognosis of unfavorable outcome in 
patients with ischemic stroke (OR 1.07, 95%CI: 1.030-1.103; AUC 0.705, optimal 
cut-off >79 years old). The medical history of ischemic stroke patients was also good 
predictors, such as diabetes, coronary heart disease, atrial fibrillation and other 
diseases [22-24]. Therefore, in our study, medical history of ischemic stroke patients 
was also included in the regression analysis. Patients in favorable outcome group 
were less likely to have atrial fibrillation (4.8% vs. 22.2%, P<0.001). Our result 
suggested AF was also a good predictor in the new model (OR 4.21, 95%CI: 1.331-
13.315; AUC 0.587). Atrial fibrillation is one of the common causes of ischemic 
stroke. Early detection and treatment of atrial fibrillation is an important measure to 
prevent ischemic stroke [25-28]. Many studies showed that atrial fibrillation was 
associated with severe cerebral infarction. No matter thrombolytic therapy was 
administered for ischemic stroke or not, patients with atrial fibrillation were more 
likely to have poor outcome than those without atrial fibrillation [29-32]. 
Many biomarkers have been shown to be associated with the prognosis of 
cerebral infarction, such as hemoglobin, albumin, total bilirubin, fasting blood glucose, 
creatinine, uric acid，prealbumin etc. [12, 13, 33-38]. These biomarkers were 
analyzed comprehensively by logistic regression in our study. Serum prealbumin was 
found to be one of the good predictors in the multivariate regression model. 
Concentration of serum prealbumin of favorable outcome group was higher than that 
of unfavorable outcome group (218.8±57.6 vs. 186.0±55.6, P＜0.001). Prealbumin 
was found to be a good predictor in the new model (OR: 0.992, 95%CI: 0.985-1.000; 
AUC: 0.661, optimal cut-off ≤180 mg/L). There might be two reasons to explain this. 
First, prealbumin was a kind of homotetrameric protein which carries thyroid 
hormone and retinol, which was one of the best indicators of patients’ nutritional 
status[39]. Low concentrations of serum prealbumin suggested malnutrition which 
was an independent risk factor for poor outcome in acute stroke [40, 41]. Second, low 
concentration of serum prealbumin was found to be related to stroke-associated 
infections [12]. Stroke-associated infection was an independent risk factor for poor 
outcome of acute cerebral infarction [42]. 
           Strength of this study was that the four predictors included in NAAP, NIHSS, 
age, AF and PA, could be obtained more easily than other predictors in acute ischemic 
stroke, which was beneficial to the early determination of prognosis of cerebral 
infarction. For example, some studies included MRI findings as predictors. Prognosis 
of ischemic stroke was determined by assessing the volume of cerebral infarction [7]. 
However, patients often failed to perform MRI in early stage of ischemic stroke in 
emergency room. In addition, a new blood biomarker, serum prealbumin was the first 
time to be included in NAAP, which could improve predictive effectiveness of 
predicting prognosis of ischemic stroke. 
Limitations 
First, our study was a single-center study among Chinese population in Guangzhou. 
The results might not be able to represent the population in China. Second, this study 
was only a development phase. Prospective multi-center studies are required to 
validate the prognostic performance of the modified prognostic model. 
  
Conclusion 
The modified prognostic model, NAAP may be a better prognostic tool for predicting 
short-term unfavorable outcome for ischemic stroke than NIHSS alone. 
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